Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma
0 ビュー
• 07/18/23
0
0
埋め込む
administrator
加入者
The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Andrew Wagner, MD, PhD; Lor Randall, MD, FACS; Shreyaskumar Patel, MD; and Jonathan Trent, MD, PhD; discuss the factors they consider when balancing the risks and benefits of chemotherapy treatment in soft tissue sarcoma.
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント